《现代医学与健康研究》编辑部官网!【中国医师协会系列期刊】
不同时机行小骨窗微创血肿清除术 治疗高血压脑出血的疗效观察
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.34

基金项目:


Clinical effect observation of minimally invasive hematoma evacuation with small bone window in the treatment of hypertensive cerebral hemorrhage at different time pionts
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨不同时机行小骨窗微创血肿清除术治疗高血压脑出血患者,对其血管内皮功能指标、炎症因子水平的影响。方法 回 顾性分析中国人民解放军联勤保障部队第九六〇医院淄博医疗区 2019 年 1 月至 2021 年 9 月期间收治的 200 例高血压脑出血患者的临床资 料,根据手术时机的不同将其分为早期组与超早期组,各 100 例。早期组患者于发病 6~24 h 内实施小骨窗微创血肿清除术,超早期组患 者于发病 6 h 内实施小骨窗微创血肿清除术,两组患者均持续随访观察 6 个月。比较两组患者术后 6 个月临床疗效,围术期指标,术前、 术后 7 d 血清白细胞介素 -6(IL-6)、超敏 -C 反应蛋白(hs-CRP)、基质金属蛋白酶 -9(MMP-9)及血清内皮素(ET)、血管生成素 -1 (Ang-1)、血管内皮生长因子(VEGF)水平,以及术后 6 个月内并发症发生情况。结果 术后 6 个月,超早期组患者临床总有效率与 早期组比显著升高,住院时间、离床活动时间、神志恢复时间与早期组比显著缩短,术中出血量与早期组比显著减少;术后 7 d 两组患者 血清 IL-6、hs-CRP、MMP-9、ET、Ang-1 水平与术前比均显著降低,且超早期组显著低于早期组;而血清 VEGF 水平均显著升高,且超 早期组显著高于早期组(均P<0.05);超早期组并发症总发生率低于早期组,但差异无统计学意义( P>0.05)。结论 与早期行小骨窗 微创血肿清除术治疗相比,超早期行手术治疗可缩短高血压脑出血患者住院时间和离床活动时间,改善神经功能,调节血管内皮功能, 减轻炎症反应,且安全性良好。

    Abstract:

    Objective To investigate the effect of minimally invasive hematoma evacuation with small bone window on vascular endothelial function indexes and inflammatory factors levels in patients with hypertensive cerebral hemorrhage at different time points. Methods A retrospective analysis was performed on the clinical data of 200 patients with hypertensive cerebral hemorrhage admitted to the Zibo Medical Area, 960th Hospital of People's Liberation Army Joint Service Support Force from January 2019 to September 2021, according to the different operation time points, they were divided into the early group and the super early group, 100 cases in each group. Patients in the early group were treated with minimally invasive hematoma evacuation with small bone window within 6~24 hours after onset, patients in the super early group were treated with minimally invasive hematoma evacuation with small bone window within 6 hours after onset, patients in both groups were observed for 6 months after operation. The clinical efficacy 6 months after operation and perioperative indexes of patients in the two groups were compared, the serum levels of interleukin-6 (IL-6), hypersensitive C-reactive protein (hs-CRP), matrix metalloproteinase-9 (MMP-9), endothelin (ET), angiopoietin-1(Ang-1), and vascular endothelial growth factor (VEGF) before and 7 d after operation, and the incidence of complications within 6 months after operation of patients in the two groups were compared. Results 6 months after operation,the total clinical response rate in the super early group was significantly higher than that in the early group, the hospital stay, ambulation time and recovery time of consciousness were significantly shorter than those in the early group, and the amount of intraoperative blood loss was significantly lower than that in the early group; compared with before operation, the serum levels of IL-6, hs-CRP, MMP-9, ET and ANG- 1 of patients in two groups 7 d after operation decreased significantly, and the super early group was significantly lower than the early group, while the serum VEGF level 7 d after operation increased significantly, and the super early group was significantly higher than the early group (all P<0.05); the total incidence of complications in the super early group was lower than that in the early group, but the difference was not statistically significant (P>0.05). Conclusion Compared with minimally invasive hematoma evacuation with small bone window in the early stage, operation in the super early stage can shorten the hospital stay and ambulation time in patients with hypertensive cerebral hemorrhage, improve nerve function, regulate vascular endothelial function, and reduce inflammatory response, and the security is good.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-25
  • 出版日期:

地址:北京朝阳区北沙滩1号16信箱

邮编:100083

电话:010-64882183 64883630

E-mail:xdyx2020@vip.163.com


温馨提示:建议您使用Chrome80、火狐74+、IE11浏览器 ,当您的浏览器版本过低,可能会影响部分功能正常使用。

现代医学与健康研究 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司